Re-Thinking Targeting Cell Division in Chemotherapy

Part of the Oncology Translational Research Conference - Andrew Holland, MD, explains the role of centrosome aberrations and aneuploidy in tumor evaluation and the development of therapeutic resistance. Dr. Holland also presents strategies for selectively targeting the cell division apparatus in tumor cells.

Created by

Johns Hopkins Greater Washington Area

Related Presenters

Andrew Holland, MD

Andrew Holland, MD

Associate Professor of Molecular Biology and Genetics

Dr. Andrew J. Holland is an assistant professor of molecular biology and genetics at the Johns Hopkins University School of Medicine and holds a secondary appointment in Oncology. Dr. Holland's research focuses on the molecular mechanisms ...

View full profile